Next Article in Journal
Bone Marrow Environment in Metastatic Neuroblastoma
Next Article in Special Issue
PARP Inhibitors in Melanoma—An Expanding Therapeutic Option?
Previous Article in Journal
Current and Novel Alkylators in Multiple Myeloma
Previous Article in Special Issue
Efficacy of BRAF and MEK Inhibition in Patients with BRAF-Mutant Advanced Melanoma and Germline CDKN2A Pathogenic Variants
 
 
Article

Article Versions Notes

Cancers 2021, 13(10), 2466; https://doi.org/10.3390/cancers13102466
Action Date Notes Link
article xml file uploaded 18 May 2021 19:18 CEST Original file -
article xml uploaded. 18 May 2021 19:19 CEST Update -
article pdf uploaded. 18 May 2021 19:19 CEST Version of Record https://www.mdpi.com/2072-6694/13/10/2466/pdf-vor
article supplementary file uploaded. 18 May 2021 19:19 CEST - https://www.mdpi.com/2072-6694/13/10/2466#supplementary
article html file updated 18 May 2021 19:20 CEST Original file -
article xml file uploaded 19 May 2021 09:04 CEST Update -
article xml uploaded. 19 May 2021 09:04 CEST Update https://www.mdpi.com/2072-6694/13/10/2466/xml
article pdf uploaded. 19 May 2021 09:04 CEST Updated version of record https://www.mdpi.com/2072-6694/13/10/2466/pdf
article html file updated 19 May 2021 09:06 CEST Update -
article html file updated 20 May 2021 08:08 CEST Update -
article html file updated 26 July 2022 20:12 CEST Update https://www.mdpi.com/2072-6694/13/10/2466/html
Back to TopTop